DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC)

47 filings reported holding DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value as of Q3 2021.
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2,804,345 shares of 51,654,406 outstanding shares and own 5.43% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (787,536 shares), Ikarian Capital, LLC (311,041 shares), JACOB ASSET MANAGEMENT OF NEW YORK LLC (275,000 shares), Manatuck Hill Partners, LLC (273,100 shares), COOPERMAN LEON G (200,000 shares), GEODE CAPITAL MANAGEMENT, LLC (167,763 shares), Stonepine Capital Management, LLC (165,775 shares), NORTHERN TRUST CORP (85,570 shares), TWO SIGMA ADVISERS, LP (80,600 shares), and TWO SIGMA INVESTMENTS, LP (74,280 shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.